Cancer Drug Discovery Group

The Cancer Drug Discovery Group (CDDG) encompasses multi-disciplinary grouping of researchers based at the University of Wollongong, Wollongong Hospital and private cancer clinics using drug design, synthetic organic/medicinal chemistry, radio-imaging, tumour cell biology, and preclinical assessment to identify and validate new and/or improved classes of chemotherapeutics and diagnostics for cancer. 

The latest figures from The Cancer Institute NSW indicate that the risk of being diagnosed with cancer is now one in two for males and one in three for females up to the age of 85 years. In 2010, more than 42,800 people died from cancer in Australia, accounting for about 3 in 10 deaths, making it the second most common cause of death¹.

Overarching aims of the CDDG are to improve our understanding of the biological processes underlying cancer, develop improved methods of detection and treatment for cancer, and apply what is known in the areas of cancer screening and cancer prevention.

The CDDG encompasses multi-disciplinary grouping of researchers based at the University of Wollongong, Wollongong Hospital and private cancer clinics using drug design, synthetic organic/medicinal chemistry, radio-imaging, tumour cell biology, and preclinical assessment to identify and validate new and/or improved classes of chemotherapeutics and diagnostics for cancer.

Information about donating to CDDG can be found on the UOW Giving webpage, as well as GiveNow.com.au.